BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/21/2024 11:37:41 AM | Browse: 212 | Download: 1139
 |
Received |
|
2023-12-23 20:26 |
 |
Peer-Review Started |
|
2023-12-23 20:26 |
 |
First Decision by Editorial Office Director |
|
2024-01-04 04:01 |
 |
Return for Revision |
|
2024-01-04 04:01 |
 |
Revised |
|
2024-01-18 19:07 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2024-03-04 02:52 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2024-03-04 04:56 |
 |
Articles in Press |
|
2024-03-04 04:56 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2024-03-18 03:24 |
 |
Publish the Manuscript Online |
|
2024-03-21 11:37 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Surgery |
| Manuscript Type |
Meta-Analysis |
| Article Title |
Effects of neoadjuvant chemotherapy vs chemoradiotherapy in the treatment of esophageal adenocarcinoma: A systematic review and meta-analysis
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Armand Csontos, Alíz Fazekas, Lajos Szakó, Nelli Farkas, Csenge Papp, Szilárd Ferenczi, Szabolcs Bellyei, Péter Hegyi and András Papp |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Armand Csontos, MD, Doctor, Doctor, Department of Surgery, University of Pécs, Medical School, Clinical Center, Ifjúság Street 13, Pécs H-7624, Baranya, Hungary. csontos.armand@gmail.com |
| Key Words |
Neoadjuvant; Chemotherapy; Chemoradiotherapy; Esophageal cancer; Adenocarcinoma |
| Core Tip |
Neoadjuvant chemoradiation increases pathological complete response and 30-d mortality in patients with esophageal adenocarcinoma; however, it has no effect on long-term survival. It may be associated with side effects that can reduce the quality of life. |
| Publish Date |
2024-03-21 11:37 |
| Citation |
Csontos A, Fazekas A, Szakó L, Farkas N, Papp C, Ferenczi S, Bellyei S, Hegyi P, Papp A. Effects of neoadjuvant chemotherapy vs chemoradiotherapy in the treatment of esophageal adenocarcinoma: A systematic review and meta-analysis. World J Gastroenterol 2024; 30(11): 1621-1635 |
| URL |
https://www.wjgnet.com/1007-9327/full/v30/i11/1621.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v30.i11.1621 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.